Business Wire - The global leader in news distribution
Updated: 22 min 34 sec ago
SASKATOON, Saskatchewan--(BUSINESS WIRE)--CanniMed Therapeutics Inc. Announces Quarterly Results Release Date
EDMONTON, Alberta & SASKATOON, Saskatchewan--(BUSINESS WIRE)--Changes to CanniMed Therapeutics Board Following Share Take-Up by Aurora Cannabis
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
Biogen to Present at the 2018 Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (Nasdaq: BIIB) will present data from its portfolio of investigational therapies for people with neurodegenerative diseases at the Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting in Torino, Italy (March 15-18, 2018). AAT-AD/PD is a new joint meeting between the International Geneva/Springfield Symposium on Advances in Alzheimer’s Therapy and AD/PD™. Alessandro Padovani M.D., Ph.D., professor of neurology and director of the I
Ferring Announces Positive Outcome of European Decentralised Procedure (DCP) for Testavan®, a Treatment for Men with Hypogonadism
SAINT PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals today announced the positive outcome of the European Decentralised Procedure (DCP) for Testavan® (transdermal testosterone gel 2%), a testosterone replacement therapy for adult male hypogonadism, when testosterone deficiency has been confirmed by clinical features and biochemical tests. The Netherlands acted as Reference Member State (RMS) on behalf of all 31 European Economic Areas (EEA) countries.1 “Men suffering from hypogonad
TORONTO--(BUSINESS WIRE)--Acerus Pharmaceuticals Corporation (TSX:ASP) will announce financial results for the three and twelve month periods ending December 31, 2017 on Wednesday, March 21, 2018 before market opens. The company will host a conference call on Wednesday, March 21, 2018 at 8:30 a.m. Eastern Time. To access the call live, please dial 416-340-2216 or 1-866-225-2055. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays. A replay of the conference cal
VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced that ZW49 is the first product candidate selected for clinical development utilizing the ZymeLink™ antibody-drug conjugate (ADC) platform, acquired as part of the Company’s 2016 acquisition of Kairos Therapeutics. ZW49 was developed by leveraging ZymeLink in combination with Zymeworks’ flagship Azymetric™ bispecific pl
VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today reported financial results for the year ended December 31, 2017. “2017 was marked by a number of key corporate successes,” said Ali Tehrani, Ph.D., Zymeworks’ President & CEO. “We continued to generate promising clinical results for ZW25, added a sixth global pharmaceutical partner, and saw important progress in our partners
Government of Canada Supports World Congress on Return to Work / Disability Management IFDM 2018 to be Held October 14-17, 2018 in Vancouver, BC, Canada
VANCOUVER, British Columbia--(BUSINESS WIRE)--The Pacific Coast University for Workplace Health Sciences (PCU-WHS) is pleased to announce that the 2018 International Forum on Disability Management (IFDM) conference will receive $75,000 through the Government of Canada’s Social Development Partnerships Program-Disability (SDPP-D) component, which helps improve the lives of children and families, people with disabilities, and other vulnerable Canadians. “Canada is at its best and all of society b
BELGRADE, Mont.--(BUSINESS WIRE)--Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) is providing this default status report in accordance with National Policy 12-203 – Management Cease Trade Orders. The Company’s audited annual financial statements, related management’s discussion and analysis and accompanying CEO and CFO certifications for the financial year ended September 30, 2017 (collectively, the “Required Filings”) would not be completed by the pre
AbCellera Awarded Multi-Year Contract to Lead the Development of a Rapid Response Platform Against Pandemic Viral Threats
VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera awarded a contract from DARPA to develop a rapid response platform to act as a countermeasure in the event of a pandemic viral outbreak.
Biogen to Acquire from Pfizer First-in-Class Phase 2b Ready Asset for Cognitive Impairment Associated with Schizophrenia
CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIOGEN TO ACQUIRE FROM PFIZER FIRST-IN-CLASS PHASE 2b READY ASSET FOR COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA
New Data Presented at MDA Clinical Conference Show Benefit in Motor Function for Infants, Teens and Young Adults Treated With SPINRAZA® (nusinersen)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--New Data Presented at MDA Clinical Conference Show Benefit in Motor Function for Infants, Teens and Young Adults Treated With SPINRAZA® (nusinersen)
MISSISSAUGA, Ontario--(BUSINESS WIRE)--#agm--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced the results of the matters voted upon at the Company’s 2018 Annual Meeting of Shareholders held March 8th 2018. Shareholders voted in favour of all items of business and each was approved by the requisite number of votes. The matters included the election of the board of directors, the appointment of auditors, and the approval of th
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Aurora Cannabis Announces Success in Bid for CanniMed Therapeutics Through the Take-Up of Shares
PointClickCare Technologies Named One of Canada’s Best Managed Companies for the Fifth Consecutive Year
TORONTO--(BUSINESS WIRE)--#health--PointClickCare Technologies Inc. has been named one of Canada’s Best Managed Companies for the fifth consecutive year.
Sephora Continues to Champion Female-Powered Beauty Businesses in Its Third Annual Sephora Accelerate Cohort
SAN FRANCISCO--(BUSINESS WIRE)--#SephoraAccelerate--SEPHORA STANDS Accelerate is dedicated to building the future of innovative female beauty entrepreneurs around the globe.
OTTAWA, Ontario--(BUSINESS WIRE)--#HR--BioTalent Canada highlights the successful first year of their participation in the Government of Canada's Student Work-Integrated Learning Program.
VANCOUVER, British Columbia--(BUSINESS WIRE)--Malachite Management Inc. announced that it has recently been awarded accreditation by Association Management Company Institute (AMCI), the global trade association representing the Association Management industry. Among 500-plus AMCs worldwide, only 81 have achieved AMC Institute Accreditation, demonstrating the commitment and the ability to deliver the highest level of professional management services to association and not-for-profit clients. The
VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will present at the upcoming Barclays Global Healthcare Conference taking place March 13-15, 2018 in Miami Beach, Florida. The company’s presentation will be March 13, 2018 at 10:45 a.m. Eastern Time. Interested parties can access a live webcast of the presentation via a link from Zymeworks’ website